Cargando…
Rocaglates as Antivirals: Comparing the Effects on Viral Resistance, Anti-Coronaviral Activity, RNA-Clamping on eIF4A and Immune Cell Toxicity
Rocaglates are potent broad-spectrum antiviral compounds with a promising safety profile. They inhibit viral protein synthesis for different RNA viruses by clamping the 5′-UTRs of mRNAs onto the surface of the RNA helicase eIF4A. Apart from the natural rocaglate silvestrol, synthetic rocaglates like...
Autores principales: | Obermann, Wiebke, Friedrich, Alexandra, Madhugiri, Ramakanth, Klemm, Paul, Mengel, Jan Philipp, Hain, Torsten, Pleschka, Stephan, Wendel, Hans-Guido, Hartmann, Roland K., Schiffmann, Susanne, Ziebuhr, John, Müller, Christin, Grünweller, Arnold |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950828/ https://www.ncbi.nlm.nih.gov/pubmed/35336926 http://dx.doi.org/10.3390/v14030519 |
Ejemplares similares
-
Broad-spectrum antiviral activity of the eIF4A inhibitor silvestrol against corona- and picornaviruses
por: Müller, Christin, et al.
Publicado: (2018) -
Comparison of broad-spectrum antiviral activities of the synthetic rocaglate CR-31-B (−) and the eIF4A-inhibitor Silvestrol
por: Müller, Christin, et al.
Publicado: (2020) -
Targeting the DEAD-Box RNA Helicase eIF4A with Rocaglates—A Pan-Antiviral Strategy for Minimizing the Impact of Future RNA Virus Pandemics
por: Taroncher-Oldenburg, Gaspar, et al.
Publicado: (2021) -
The rocaglate CR-31-B (−) inhibits SARS-CoV-2 replication at non-cytotoxic, low nanomolar concentrations in vitro and ex vivo
por: Müller, Christin, et al.
Publicado: (2021) -
Comparing the Effects of Rocaglates on Energy Metabolism and Immune Modulation on Cells of the Human Immune System
por: Schiffmann, Susanne, et al.
Publicado: (2023)